Skip to content
HowShorted

HERON THERAPEUTICS, INC. short interest in 2020

In 2020, HERON THERAPEUTICS, INC.'s disclosed short interest ran from 20.12% of shares outstanding on 15 Jan 2020 to 19.29% on 31 Dec 2020, a change of -0.83 percentage points. The year's high was 21.56% on 28 Feb 2020 and its low 16.85% on 31 Aug 2020, averaging 19.15% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 31.93 days on 14 Feb 2020. Full history: HERON THERAPEUTICS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for HERON THERAPEUTICS, INC. in 2020

2020 in figures

Start of year
20.12% (15 Jan 2020)
End of year
19.29% (31 Dec 2020)
Change
-0.83 pp
High
21.56% (28 Feb 2020)
Low
16.85% (31 Aug 2020)
Average
19.15%
Highest days to cover
31.93 (14 Feb 2020)
SEC filings marked
9

Every report in 2020

HERON THERAPEUTICS, INC. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202020.12%14.63results (8-K)
31 Jan 202020.61%15.54
14 Feb 202021.13%31.93
28 Feb 202021.56%12.70
13 Mar 202020.04%11.9310-K filed, results (8-K)
31 Mar 202018.42%8.90
15 Apr 202018.36%19.90
30 Apr 202018.89%19.43
15 May 202018.37%16.6510-Q filed, results (8-K)
29 May 202018.33%19.13
15 Jun 202018.81%20.31
30 Jun 202020.73%7.26
15 Jul 202018.68%11.02
31 Jul 202017.66%20.94
14 Aug 202017.91%20.7910-Q filed, results (8-K)
31 Aug 202016.85%29.84
15 Sep 202016.99%18.27
30 Sep 202018.76%20.62
15 Oct 202019.14%29.57
30 Oct 202019.24%31.43
13 Nov 202019.92%23.8510-Q filed, results (8-K)
30 Nov 202020.43%22.88
15 Dec 202019.37%19.14
31 Dec 202019.29%12.98

See also: HERON THERAPEUTICS, INC.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.